Alliance for Aging Research Study Finds that Alzheimer’s Disease Is Not Bankrupting Medicare, But It Is Taking a Huge Toll on State Medicaid Programs and Family Caregivers.


The Real-World Medicare Costs of Alzheimer Disease: Considerations for Policy and Care” findings published in the July issue of Journal of Managed Care and Specialty Pharmacy, demonstrate the importance of better diagnosis, treatment, and care of individuals with Alzheimer’s, which could lead to more favorable patient outcomes and improved costs for state Medicaid programs and caregivers.

Previous Article

A Deep Data Dive: Opioid-Related Hospital Care for Seniors

Next Article

Many with Opioid Addiction Don’t Get Meds that Can Help